Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression

Journal of Clinical Pharmacy and Therapeutics

Volumn 28, Issue 5, 2003, Pages 379-384

  Akhondzadeh, S ^a,b,d   Faraji, H ^a   Sadeghi, M ^a   Afkham, K ^a   Fakhrzadeh, H ^c   Kamalipour, A ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Institute of Medicinal Plants Iran   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d NONE   (Iran)

Author keywords

Cardiovascular effects; Depression; Fluoxetine; Nortriptyline

Indexed keywords

FLUOXETINE; NORTRIPTYLINE;

ABDOMINAL PAIN; ADULT; APPETITE DISORDER; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIPLOPIA; DOUBLE BLIND PROCEDURE; DROWSINESS; ELECTROCARDIOGRAM; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; HYPERHIDROSIS; HYPERTENSION; MAJOR DEPRESSION; MALE; MELANCHOLIA; MORTALITY; NAUSEA; OCCUPATION; ORTHOSTATIC HYPOTENSION; PARESTHESIA; PRURITUS; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; RISK FACTOR; SEXUAL DYSFUNCTION; SKIN TINGLING; SLEEP DISORDER; SOCIAL INTERACTION; TACHYCARDIA; TREMOR; URINE RETENTION; VERTIGO; VISUAL IMPAIRMENT; VOMITING; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; NORTRIPTYLINE;

EID: 0242330348     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0269-4727.2003.00505.x     Document Type: Article

References (20)

1. Baker GB, Coutts RT, Greenshaw AJ (2000) Neurochemical and metabolic aspects of antidepressants: an overview. Journal of Psychiatry and Neuroscience, 25, 481-496.
2. Greenberg P, Stiglin LE, Finkelstein S (1993) Depression: a neglected major illness. Journal of Clinical Psychiatry, 54, 419-424.
3. Judd L (1995) Mood disorders in the general population represent an important and worldwide public health problem. International Journal of Clinical Psychopharmacology, 10 (Suppl), 5-10.
4. Mendlewich J (2001) Optimizing antidepressant use in clinical practice: towards criteria for antidepressant selection. The Br. Journal of Psychiatry, 179(Suppl), 1-3.
5. Siegfried K (1997) Efficacy of antidepressants in the treatment of severe depression: The place of mitrazapine. Journal of Clinical Psychopharmacology, 17(Suppl), 19S-28S.
6. Gordon P (2001) New and old antidepressants: all equal in the eyes of the lore? British Journal of Psychiatry, 179, 95-96.
7. Hirscfeld RMA (1999) Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. Journal of Clinical Psychiatry, 60, 326-335.
8. Anderson I (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta analysis of efficacy and tolerability. Journal of Affective Disorders, 58, 19-36.
9. Bech P, Cialdella P, Haugh M, Birkett MA, Hours A, Boissel JP, Tollefson GD (2000) Mata-analysis of randomized controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression. British Journal of Psychiatry, 176, 421-428.
10. Isaac M (1999) Where are we going with SSRIs? European Neuropsychopharmacology, 9 (Suppl), S101-S106.
11. Roose SR (2000) Considerations for the use of antidepressants in patients with cardiovascular disease. American Heart Journal 140, S84-S88.
12. Navarro V, Gasto C, Torres X, Marcos T, Pintor L (2001) Citalopram versus nortriptyline on late-life depression: a 12-week randomized single-blind study. Acta Psychiatricia Scandinavian, 103, 435-440.
13. Gasto C, Navarro V, Marcos T, Porella MJ, Torra M, Rodanmilas M (2003) Single-blind comparison of venlafaxine and nortriptyline in elderly major depression. Journal of Clinical Psychopharmacology, 23, 21-26.
14. Joyce PR, Mulder RT, Luty SE, Sullivan PF, McKenzie JM, Abbott RM, Stevens IF (2002) Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Australian and News land Journal of Psychiatry, 36, 384-391.
15. Thompson C, Peveler RC, Stephenson D, McKendrick J (2000) Compliance with antidepressant medication in the treatment of major depressive disorder in primary care: A randomized comparison of fluoxetine and a tricyclic antidepressant. American Journal of Psychiatry, 157, 338-343.
16. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. (DSM-IV). Washington DC: American Psychiatric Association.
17. Hamilton M (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 62-66.
18. British Association for Psychopharmacology (1993) Guidelines for treating depressive illness with antidepressants. Journal of Psychopharmacology, 7, 19-23.
19. Richelson E (1994) Pharmacology of antidepressants-characteristic of the ideal drug. Mayo Clinic Proceeding, 69, 1069-1081.
20. Demyttenaere K (1997) Compliance during treatment with antidepressants. Journal of Affective Disorders, 43, 27-39.